The invention relates to the field of medicine and the pharmaceutical-chemical industry, and specifically to the field of neurology, and concerns new compositions containing memantine and melatonin. It has been established that a strengthening of the effect of memantine takes place when it is combined with melatonin. The invention may be realized through the preparation of a finished pharmaceutical product such as capsules, preferably hard gelatin capsules.